Decreased circulating miRNA levels in patients with primary progressive multiple sclerosis

Area of Science:

• Neuroimmunology
• Molecular Biology
• Biomarker Discovery

Background:

• MicroRNAs (miRNAs) are increasingly recognized for their role in the pathogenesis of multiple sclerosis (MS).
• Investigating cell-free circulating miRNAs in serum offers a non-invasive approach to understand disease mechanisms.

Purpose of the Study:

• To investigate and validate alterations in circulating miRNA levels in patients with multiple sclerosis.
• To explore the correlation between specific miRNA levels and disease severity, particularly the Expanded Disability Status Scale (EDSS) in primary progressive MS (PPMS).

Main Methods:

• Serum samples were collected from MS patients and healthy controls.
• Quantitative real-time PCR was used to measure the levels of specific miRNAs.
• Statistical analyses were performed to identify significant differences and correlations.
• Validation in independent patient cohorts ensured the robustness of findings.

Main Results:

• Statistically significant decreased levels of miR-15b, miR-23a, and miR-223 were observed in MS patients compared to controls (p < 0.05).
• These findings were consistently replicated across two independent MS populations.
• A significant negative correlation was found between the levels of these miRNAs and the EDSS score in PPMS patients (p < 0.007).

Conclusions:

• The generalized down-regulation of specific circulating miRNAs in MS suggests a potential mechanism involving the over-expression of their target genes in disease pathogenesis.
• Circulating miRNA profiling presents a promising avenue for identifying novel, easily detectable biomarkers for multiple sclerosis.